Featured Article

Perioperative Considerations for Patients on GLP1 Agonists Advances | refreshing transformation

Heather Aug 05, 2026

Perioperative Considerations for Patients on GLP1 Agonists

Perioperative Considerations for Patients on GLP1 Agonists Advances
Perioperative Considerations for Patients on GLP1 Agonists Advances

GlP-1 receptor agonists are a class of medications that are becoming increasingly popular. Large trials have shown that their use provides reliable weight loss in obese patients and improved glycemic control in diabetic patients . Its use also has broader implications for overall metabolic health and has been shown to improve cardiovascular outcomes in high-risk populations. Glucagon-like ...

GLP 1 Receptor Agonists What Are the Side Effects
GLP 1 Receptor Agonists What Are the Side Effects

Evaluation and risk assessment of patients taking GLP-1 receptor agonists and undergoing anesthesia represent a new challenge for anesthesia providers.

New Multi

PDF The potential of GLP 1 receptor agonists in type 2 diabetes
PDF The potential of GLP 1 receptor agonists in type 2 diabetes

Most patients should continue taking their glucagon-like peptide-1 ( GLP-1 ) receptor agonists before elective surgery, suggests new clinical guidance released by the American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and the Society of ...

The perioperative management of patients using glucagon-like peptide 1 receptor agonists remains a topic of debate. While several multisociety statements have been published recently, the recommendations vary significantly in terms of medication management and preoperative fasting protocols for these patients . This document represents a multidisciplinary consensus statement led by the Society ...

Evidence for Cardiorenal Protection with SGLT 2 Inhibitors and GLP 1
Evidence for Cardiorenal Protection with SGLT 2 Inhibitors and GLP 1

Perioperative management of patients taking glucagon

Summary The perioperative management of patients using glucagon-like peptide 1 receptor agonists remains a topic of debate. While several multisociety statements have been published recently, the recommendations vary significantly in terms of medication management and preoperative fasting protocols for these patients .

This flowchart outlines the steps for managing patients on GLP-1 receptor agonists during the perioperative period, including risk assessment, preoperative preparation, anesthesia induction, and postoperative monitoring.

Glucagon Like Peptide 1 Receptor Agonists and Heart Failure
Glucagon Like Peptide 1 Receptor Agonists and Heart Failure

Multisociety Clinical Practice Guidance for the Safe Use of Glucagon ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized the care of patients with metabolic disease due in part to the agonists' unique combination of effects, including decreasing hyperglycemia and enhancement of satiety.1,2 GLP-1 , a naturally secreted polypeptide, acts on the GLP-1R in multiple organs, including the pancreas, brain, heart, kidney, and stomach.3 In the ...

Patients taking glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic peptide receptor agonists should: continue these drugs before surgery; have full risk assessment and stratification; and receive peri-operative techniques that may mitigate risk of pulmonary aspiration before, during and after sedation or general ...

SGLT2 Inhibitors vs GLP 1 Agonists to Treat the Heart the Kidneys
SGLT2 Inhibitors vs GLP 1 Agonists to Treat the Heart the Kidneys

PDF American Society of Anesthesiologists Consensus

American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 ( GLP-1 ) Receptor Agonists Update: In October 2024, ASA issued an Affirmation of Value for a more recent, multi

Transforming obesity The advancement of multi receptor drugs Cell
Transforming obesity The advancement of multi receptor drugs Cell
Frontiers
Frontiers
PDF GLP 1 receptor agonists impact on cardio renal outcomes
PDF GLP 1 receptor agonists impact on cardio renal outcomes
The Beneficial Effects of GLP 1 Receptor Agonists Other than Their Anti
The Beneficial Effects of GLP 1 Receptor Agonists Other than Their Anti
SGLT2 Inhibitors and GLP 1 Receptor Agonists in Kidney Transplantation
SGLT2 Inhibitors and GLP 1 Receptor Agonists in Kidney Transplantation
GLP1R靶点介绍及药物研究进展 缔码生物
GLP1R靶点介绍及药物研究进展 缔码生物
GLP 1 Receptor Agonists and Diabetic Kidney Disease A Call
GLP 1 Receptor Agonists and Diabetic Kidney Disease A Call
GLP 1 receptor agonists effects on established and presumed drivers
GLP 1 receptor agonists effects on established and presumed drivers

American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 ( GLP-1 ) Receptor Agonists Update: In October 2024, ASA issued an Affirmation of Value for a more recent, multi-society guidance GLP-1 document. Read more ...